Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02646488 · ClinicalTrials.gov registry record · NA
Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease
A NA study of Cardiovascular Disease and High Blood Pressure, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
- 1
- Study location
NCT02646488: Completed NA study of Cardiovascular Disease and High Blood Pressure, sponsored by NYU Langone Health.
NCT02646488 is a NA study of Cardiovascular Disease and High Blood Pressure that has completed, run by NYU Langone Health. The registered enrollment target is 276 participants, below the 2,695-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02646488, a NA study of Cardiovascular Disease and High Blood Pressure, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of this study is to evaluate the effectiveness of practice facilitation as a quality improvement strategy for implementing the Million Hearts' ABCS treatment guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive care in primary care practices in New York City. The ABCS refer to the following: Aspirin in high-risk individuals (A), Blood pressure control and management (B), Cholesterol management (C), and Smoking cessation (S). The long-term goal is to create a robust infrastructure to disseminate and implement evidence based practice guidelines (EBPG) findings in primary care practices and improve practices' capacity to receive and implement other EBPG findings in the future.
Conditions Studied
Interventions
- BEHAVIORAL Million Hearts ABCS 6 Months
- BEHAVIORAL Million Hearts ABCS 9 Months
- BEHAVIORAL Million Hearts ABCS 12 Months
- BEHAVIORAL Million Hearts ABCS 15 Months
- BEHAVIORAL Standard Care Regimen 9 Months
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2015-08 |
| Est. Completion | 2019-04-01 |
| Phase | NA |
What the finished NCT02646488 record still lists
NCT02646488 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 2,695-participant average among 137 other Cardiovascular Disease trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Cardiovascular Disease appearing as the primary indexed condition, and to 5 interventions - of which Million Hearts ABCS 6 Months is the first listed.
NCT02646488 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02646488 about?
NCT02646488 is a clinical study titled "Using Practice Facilitation in Primary Care Settings to Reduce Risk Factors for Cardiovascular Disease". The primary purpose of this study is to evaluate the effectiveness of practice facilitation as a quality improvement strategy for implementing the Million Hearts' ABCS treatment guidelines for reducing cardiovascular disease (CVD) among high-risk patients who receive care in primary care practices i...
What is the current status of trial NCT02646488?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2015-08. Estimated completion is 2019-04-01.
What conditions does trial NCT02646488 study?
This clinical trial studies the following conditions: Cardiovascular Disease, High Blood Pressure.
What interventions are being tested in trial NCT02646488?
The interventions under investigation include: Million Hearts ABCS 6 Months (BEHAVIORAL), Million Hearts ABCS 9 Months (BEHAVIORAL), Million Hearts ABCS 12 Months (BEHAVIORAL), Million Hearts ABCS 15 Months (BEHAVIORAL), Standard Care Regimen 9 Months (BEHAVIORAL).
Who is sponsoring clinical trial NCT02646488?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02646488 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02646488's enrollment target sits among peer trials
276 44th of 137 higher than 94 of 137 other Cardiovascular Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
RECRUITING · NA
-
A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
RECRUITING · NA
-
Gauging Outcomes of Total Milk Ingestion on Lipid and gControl
RECRUITING · NA
-
Determining the Benefits of Exercise on Cardiovascular Risk in PTSD
RECRUITING · NA
-
Century Trial, a Randomized Lifestyle Modification Study for Management of Stable Coronary Artery Disease
ACTIVE NOT RECRUITING · NA
-
Nitric Oxide Bioavailability and Early Life Stress (NO-Stress)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia